In a report released today, Greg Gibas from Northland Securities maintained a Hold rating on Trupanion (TRUP – Research Report), with a price target of $30.00. The company’s shares closed yesterday at $22.87.
According to TipRanks, Gibas is a 5-star analyst with an average return of 18.3% and a 45.83% success rate.
Trupanion has an analyst consensus of Moderate Buy, with a price target consensus of $37.67, implying a 64.71% upside from current levels. In a report released today, Piper Sandler also maintained a Hold rating on the stock with a $28.00 price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $69.15 and a one-year low of $18.45. Currently, Trupanion has an average volume of 626.8K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Trupanion (TRUP) Company Description:
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.
Read More on TRUP:
- Trupanion Announces the Winners of its truFame Campaign
- Trupanion, Inc. Announces Third Quarter 2023 Earnings Release and Conference Call
- Trupanion Celebrates National Veterinary Technician Week: Honoring the Heart of Veterinary Care
- Trupanion to Participate in the Jefferies 2023 Virtual Pet Care & Wellness Conference
- Trupanion Announces Appointment of Fawwad Qureshi as Chief Financial Officer
